SALIX PHARMACEUTICALS LTD Deferred Tax Assets, in Process Research and Development
SALIX PHARMACEUTICALS LTD had Deferred Tax Assets, in Process Research and Development of $19.00 thousand as of 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment · last filed 2015-03-02
- 2014-12-31: Deferred Tax Assets, in Process Research and Development $19.00K.
- 2013-12-31: Deferred Tax Assets, in Process Research and Development $81.00K.
- 2012-12-31: Deferred Tax Assets, in Process Research and Development $140.00K.
- 2011-12-31: Deferred Tax Assets, in Process Research and Development $275.00K; Deferred Tax Assets, in Process Research and Development as first filed $17.26M.
| Period end | Deferred Tax Assets, in Process Research and Development | Deferred Tax Assets, in Process Research and Development as first filed |
|---|---|---|
| 2014-12-31 | $19.00K 10-K · filed 2015-03-02 | |
| 2013-12-31 | $81.00K 10-K · filed 2015-03-02 | |
| 2012-12-31 | $140.00K 10-K · filed 2015-03-02 | |
| 2011-12-31 | $275.00K 10-K · filed 2013-03-01 | $17.26M 10-K · filed 2012-02-28 |
| 2010-12-31 | $20.63M 10-K · filed 2012-02-28 |